JERI STEPHENSON: Open Payments
NPI 1154348845 · LANSING, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 18 payments from 12 companies in 2025. Trend: 2023 $384 · 2024 $439 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $49 |
| ABBVIE INC. | 2 | $43 |
| Abbott Laboratories | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| CSL Behring | 1 | $35 |
| Exact Sciences Corporation | 2 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Astellas Pharma US Inc | 1 | $25 |
| Dexcom, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: QULIPTA, FREESTYLE LIBRE 3, CAPLYTA, Andembry, Wegovy, MOUNJARO, Veozah, Dexcom G6 Transmitter.
Industry payments across KS — which companies pay providers there.
